MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+3.54%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$233M
AUM Growth
+$233M
(-2%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $76.9M | 32.93% | 19,963,157 | – | – |
|
2
Vaxcyte
PCVX
$4B
| $54.6M | 23.4% | 1,457,300 | – | – |
|
3
Merus
MRUS
$4.98B
| $29.4M | 12.61% | 1,600,000 | – | – |
|
4
Aura Biosciences
AURA
$389M
| $28.2M | 12.09% | 3,039,892 | – | – |
|
5
NewAmsterdam Pharma
NAMS
$2.71B
| $26.5M | 11.36% | 2,000,000 | – | – |
|
6
Phathom Pharmaceuticals
PHAT
$864M
| $17.7M | 7.6% | 2,484,274 | – | – |
|